Yersinia pestis infection natural history, complications and prognosis: Difference between revisions
Esther Lee (talk | contribs) No edit summary |
Esther Lee (talk | contribs) |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
If plague patients are not given specific antibiotic therapy, the disease can progress rapidly to death. About 14% (1 in 7) of all plague cases in the United States are fatal. | |||
==Natural history, complications and prognosis== | ==Natural history, complications and prognosis== |
Revision as of 19:04, 26 September 2012
Yersinia pestis infection Microchapters |
Differentiating Yersinia Pestis Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Yersinia pestis infection natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Yersinia pestis infection natural history, complications and prognosis |
FDA on Yersinia pestis infection natural history, complications and prognosis |
CDC on Yersinia pestis infection natural history, complications and prognosis |
Yersinia pestis infection natural history, complications and prognosis in the news |
Blogs on Yersinia pestis infection natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assistant Editors-In-Chief: Esther Lee, M.A.
Overview
If plague patients are not given specific antibiotic therapy, the disease can progress rapidly to death. About 14% (1 in 7) of all plague cases in the United States are fatal.
Natural history, complications and prognosis
Complications
Since the Yersinia pestis are blood-borne, several organs can be affected, including the spleen and brain. The diffuse infection can cause an immunologic cascade to occur, leading to disseminated intravascular coagulation (DIC), which in turn results in bleeding and necrotic skin and tissue. Such a disseminated infection increases mortality to 22%.